
|Articles|July 15, 2006
Prophylactic, therapeutic use of mitomycin-C considered safe
Literature review shows single application of low-dose MMC can prevent, treat haze after surface procedures
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
2
AAO 2025: Advancements in laser refractive surgery
3
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
4
Q&A: Anat Loewenstein discusses the use of home OCT
5


















































.png)


